You have 6 free searches left this month | for more free features.

Chronic Uveitis

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Uveitis, Posterior, Uveitis, Anterior, Uveitis, Intermediate Trial in Waltham (Ixekizumab Prefilled Syringe)

Recruiting
  • Uveitis, Posterior
  • +3 more
  • Ixekizumab Prefilled Syringe
  • Waltham, Massachusetts
    Massachusetts Eye Research and Surgery Institution
Oct 11, 2023

YUTIQ® 0.18 mg Intravitreal Implant for Management of Chronic

Recruiting
  • Uveitis
  • YUTIQ
  • Tianjin, Tianjin, China
    Tianjin Medical University Eye Hospital
Oct 23, 2022

Minocycline, Uveitis, Retinal Degeneration Trial in Guangzhou (minocycline)

Recruiting
  • Minocycline
  • +2 more
  • Guangzhou, Guangdong, China
    Zhongshan Ophthalmic Center
Jul 24, 2022

Uveitis, Uveitis, Posterior, Uveitis, Intermediate Trial in Waltham (Sham Injector, FAI Insert)

Active, not recruiting
  • Uveitis
  • +2 more
  • Sham Injector
  • FAI Insert
  • Waltham, Massachusetts
    EyePoint Study Site
Dec 20, 2022

Uveitis, Uveitis, Posterior, Uveitis, Anterior Trial in Plano (Yutiq 0.18 MG Drug Implant, Sham Injection)

Not yet recruiting
  • Uveitis
  • +3 more
  • Yutiq 0.18 MG Drug Implant
  • Sham Injection
  • Plano, Texas
    Texas Retina Associates
Aug 3, 2022

Uveitis, Posterior Trial in United States (Fluocinolone Acetonide Intravitreal Implant 0.18 mg)

Recruiting
  • Uveitis, Posterior
  • Fluocinolone Acetonide Intravitreal Implant 0.18 mg
  • Phoenix, Arizona
  • +16 more
Aug 18, 2022

Uveitis Trial in Worldwide (Baricitinib, Adalimumab)

Recruiting
  • Uveitis
  • Nîmes, Gard, France
  • +22 more
Nov 9, 2022

Non-infectious Uveitis Trial in Cleveland, Arlington, Houston (EYS606)

Completed
  • Non-infectious Uveitis
  • EYS606
  • Cleveland, Ohio
  • +2 more
Mar 9, 2022

Uveitis Trial in Wroclaw (Surveillance card)

Recruiting
  • Uveitis
  • Surveillance card
  • Wrocław, Poland
    Department of Ophthalmology
Apr 16, 2021

Autoimmune Diseases, IBD, Crohn Disease (CD) Trial in Aabenraa, Herlev, Odense (Primary exposure variable, Other (exploratory)

Completed
  • Autoimmune Diseases
  • +9 more
  • Primary exposure variable
  • Other (exploratory) exposure variables
  • Aabenraa, Denmark
  • +2 more
Jun 30, 2021

Non-Infectious Uveitis Trial in Worldwide (FAI insert, Sham injection)

Completed
  • Non-Infectious Uveitis
  • FAI insert
  • Sham injection
  • Beverly Hills, California
  • +33 more
Mar 5, 2021

Posterior Uveitis, Intermediate Uveitis, Panuveitis Trial in India (Sham Injection, FAI Insert)

Completed
  • Posterior Uveitis
  • +2 more
  • Sham Injection
  • FAI Insert
  • Hyderabad, Andhra Pradesh, India
  • +14 more
Jul 10, 2020

Non-infectious Uveitis Trial in Worldwide (PP-001)

Unknown status
  • Non-infectious Uveitis
  • Vienna, Austria
  • +8 more
Mar 10, 2020

Chronic Uveitis Trial in Worldwide (Gevokizumab)

Terminated
  • Chronic Uveitis
  • Gevokizumab
  • Nedlands, Australia
  • +12 more
Jan 2, 2020

Juvenile Idiopathic Arthritis Associated Uveitis Trial in Cairo (biologic DMARDs)

Active, not recruiting
  • Juvenile Idiopathic Arthritis Associated Uveitis
  • biologic DMARDs
  • Cairo, Egypt
    Faculty of medicine, Cairo university
Sep 12, 2022

Imaging of Uveitis Patients Receiving Injectable Fluocinolone

Recruiting
  • Uveitis
  • Fluocinolone Acetonide
  • Cleveland, Ohio
    Cole Eye Institute Cleveland Clinic Foundation
Apr 27, 2022

Uveitis With Biologic Drugs in Resistant Cases

Not yet recruiting
  • Uveitis
  • Biologic drugs
  • (no location specified)
Apr 21, 2022

Uveitis, JIA Trial in Australia, United Kingdom, United States (Adalimumab, Placebo)

Recruiting
  • Uveitis
  • JIA
  • Adalimumab
  • Placebo
  • Sacramento, California
  • +24 more
Mar 9, 2022

Uveitis Trial in Miami (Norflo Oro, Placebo for Norflo Oro)

Completed
  • Uveitis
  • Norflo Oro
  • Placebo for Norflo Oro
  • Miami, Florida
    Bascom Palmer Eye Institute
Mar 25, 2022

Uveitis Trial in United Kingdom

Recruiting
  • Uveitis
    • Belfast, United Kingdom
    • +30 more
    May 19, 2022

    Juvenile Idiopathic Arthritis Trial in United States (Abatacept Injection, Usual Care)

    Recruiting
    • Juvenile Idiopathic Arthritis
    • Abatacept Injection
    • Usual Care
    • Birmingham, Alabama
    • +25 more
    Aug 16, 2022

    Uveitis, Macular Edema, Vascular Endothelial Growth Factor Trial in Beijing (intravitreal injection of Conbercept)

    Terminated
    • Uveitis
    • +3 more
    • intravitreal injection of Conbercept
    • Beijing, Beijing, China
      Peking Union Medical College Hospital (PUMCH)
    Oct 24, 2022

    Uveitis Trial in Guangzhou (Adalimumab plus Methotrexate)

    Recruiting
    • Uveitis
    • Adalimumab plus Methotrexate
    • Guangzhou, Guangdong, China
      Zhongshan Ophthalmic Center, Sun Yat-sen University
    Dec 26, 2021

    Pediatric Uveitis Patients

    Not yet recruiting
    • Uveitis
      • Assiut, Egypt
      • +1 more
      Oct 1, 2023

      Behçet Disease Trial in Paris (Subcutaneous Ustekinumab)

      Completed
      • Behçet Disease
      • Subcutaneous Ustekinumab
      • Paris, France
        Hôpital Cochin, Department of Internal Medicine, National Refere
      Nov 19, 2021